See What HealthDay Can Do For You
Contact Us

Formaldehyde May Endanger Funeral Workers

Leukemia risk is found to increase with longer exposure to embalming fluids

FRIDAY, Nov. 20, 2009 (HealthDay News) -- Long-term exposure to formaldehyde used for embalming increases funeral industry workers' risk of death from myeloid leukemia, according to a new U.S. government study.

Researchers in the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute analyzed data on funeral industry workers who died between 1960 and 1986. Information about the workers' work practices and exposure to formaldehyde throughout their lifetime was collected through interviews with family members and co-workers.

The researchers found that risk rose along with the number of years someone had been involved with embalming and related formaldehyde exposure. The greatest risk was seen among those who'd been involved in embalming for more than 20 years, according to the study.

The findings were published online Nov. 20 in the Journal of the National Cancer Institute.

"This study adds supporting and complementary data to other epidemiological evidence of an association between formaldehyde exposure and risk of myeloid leukemia," the researchers wrote.

"Further studies of leukemia risk in relation to specific embalming practices and exposures, as well as similar specific exposure studies in other professional groups that are exposed to formaldehyde and that have an increased risk of leukemia, should help to clarify our understanding of cancer risks related to formaldehyde," they added.

More information

The American Cancer Society has more about myeloid leukemia.

SOURCE: Journal of the National Cancer Institute, news release, Nov. 20, 2009
Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.